Bio-Shield 2019-nCoV Total Immunoglobulins (C1348/C1396)

Bio Shield

Principle: Double antigen sandwich ELISA method

Automation: Yes

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: For Medical Professionals and Scientists

Capital equipment required: Yes, A typical ELISA photometer

Description:

Bio-Shield 2019-nCoV Total Immunoglobulins, is a semi-quantitative ELISA test for the determination of IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.


Key Points:
  • Semi-quantitative ELISA test with single-break strip plate with 48 wells (6 strips) or 96 wells (12 strips)
  • Clinical Diagnostic Sensitivity 98,68%, 75/76 (CI: 0.93 to 0.9977), Clinical Diagnostic Specificity 100%, 86/86 (CI: 0.9572 to 1)
  • Test time: 120 min
  • Compatible with automated ELISA systems
  • Shelf Life: 12 months | Storage 2-8 °C
Company contact details:

ProGnosis Biotech S.A view full details
Greece

Website: Visit Website
Tel: + 30-2410623922






Get our eNewsletter
Over 6,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS